Education Library

Junya Ako, MD, discusses the J-PVAD registry and study data presented at TCT 2022 with Prof. Hermann Reichenspurner.

Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation from TCT 2022.

Katherine Kunkel, MD, discusses data-driven decision making and best practices in cardiogenic shock at TCT 2022. 

Navin Kapur, MD, presents lessons learned in the STEMI DTU™ pilot trial in this presentation from TCT 2022. 

Seth Bilazarian, MD, and Chuck Simonton, MD, recap highlights from day 1 of TCT 2022 and interview Greg Stone, MD and Alaide Chieffo, MD, FESC.

Kate Kearney, MD, presents a case and discusses contemporary techniques for optimal outcomes in high-risk PCI at TCT 2022. 

This recap of highlights from day 2 of TCT 2022 includes interviews with Drs. Sanjit Jolly, Navin Kapur, Adrian Attinger-Toller, and Taishi Hirai.

Day 3 highlights from TCT 2022 include several late-breaking trials and interviews with Navin Kapur, MD, and Koichi Toda, MD, PhD.

Adam Salisbury, MD, presents preliminary results from the OPTIMUM Study at TCT 2022.

At TCT 2022, Jonathan Hill, MD, presents the influential high-risk PCI trials shaping the future of ischemic heart failure therapy.

At TCT 2022, Jonathan Hill, MD, presents the influential high-risk PCI trials shaping the future of ischemic heart failure therapy.

Junya Ako, MD, presents outcomes in AMI cardiogenic shock from Japan’s J-PVAD study at TCT 2022.

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

Gregg Stone, MD, FACC, FSCAI interviews Prof. Divaka Perera, professor of cardiology at Kings College in London, UK at the European Society of Cardiology (ESC) Congress 2022 in Barcelona, Spain. Dr.

Aditya Bharadwaj, MD, an investigator for the RESTORE EF study, presents a case study epitomizing the results from the trial.